{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T08:17:47Z","timestamp":1769847467705,"version":"3.49.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["5R01 AI089634-01"],"award-info":[{"award-number":["5R01 AI089634-01"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI092434-01A1"],"award-info":[{"award-number":["AI092434-01A1"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007172","name":"Cincinnati Children's Hospital Medical Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007172","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.vaccine.2015.12.068","type":"journal-article","created":{"date-parts":[[2016,1,9]],"date-time":"2016-01-09T02:09:33Z","timestamp":1452305373000},"page":"905-913","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["A trivalent vaccine candidate against hepatitis E virus, norovirus, and astrovirus"],"prefix":"10.1016","volume":"34","author":[{"given":"Ming","family":"Xia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dianjun","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang-Jin","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2015.12.068_bib0005","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.3201\/eid1408.071114","article-title":"Systematic literature review of role of noroviruses in sporadic gastroenteritis","volume":"14","author":"Patel","year":"2008","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2015.12.068_bib0010","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/978-3-7091-6553-9_31","article-title":"The changing epidemiology of astrovirus-associated gastroenteritis: a review","volume":"12","author":"Glass","year":"1996","journal-title":"Arch Virol Suppl"},{"key":"10.1016\/j.vaccine.2015.12.068_bib0015","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/rmv.522","article-title":"Hepatitis E virus","volume":"17","author":"Panda","year":"2007","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.vaccine.2015.12.068_bib0020","doi-asserted-by":"crossref","first-page":"e228","DOI":"10.1016\/j.ijid.2012.11.026","article-title":"Hepatitis E virus: the current scenario","volume":"17","author":"Kumar","year":"2013","journal-title":"Int J Infect Dis: IJID"},{"key":"10.1016\/j.vaccine.2015.12.068_bib0025","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/S0140-6736(12)61728-0","article-title":"Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Lozano","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2015.12.068_bib0030","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/nbt0412-300a","article-title":"First HEV vaccine approved","volume":"30","author":"Proffitt","year":"2012","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.vaccine.2015.12.068_bib0035","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1126\/science.286.5438.287","article-title":"X-ray crystallographic structure of the Norwalk virus capsid","volume":"286","author":"Prasad","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2015.12.068_bib0040","doi-asserted-by":"crossref","first-page":"33175","DOI":"10.1074\/jbc.M110.106336","article-title":"Structure of hepatitis E virion-sized particle reveals an RNA-dependent viral assembly pathway","volume":"285","author":"Xing","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2015.12.068_bib0045","first-page":"237","article-title":"Human astrovirus coat protein: a novel C1 inhibitor","volume":"632","author":"Krishna","year":"2008","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.vaccine.2015.12.068_bib0050","doi-asserted-by":"crossref","first-page":"e1000537","DOI":"10.1371\/journal.ppat.1000537","article-title":"Dimerization of hepatitis E virus capsid protein E2s domain is essential for virus\u2013host interaction","volume":"5","author":"Li","year":"2009","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2015.12.068_bib0055","doi-asserted-by":"crossref","first-page":"5340","DOI":"10.1128\/JVI.00135-08","article-title":"Structural basis for the receptor binding specificity of Norwalk virus","volume":"82","author":"Bu","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.12.068_bib0060","doi-asserted-by":"crossref","first-page":"5949","DOI":"10.1128\/JVI.00219-07","article-title":"Structural basis for the recognition of blood group trisaccharides by norovirus","volume":"81","author":"Cao","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.12.068_bib0065","doi-asserted-by":"crossref","first-page":"e1002152","DOI":"10.1371\/journal.ppat.1002152","article-title":"Crystallography of a lewis-binding norovirus, elucidation of strain-specificity to the polymorphic human histo-blood group antigens","volume":"7","author":"Chen","year":"2011","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2015.12.068_bib0070","doi-asserted-by":"crossref","first-page":"9175","DOI":"10.1073\/pnas.0803275105","article-title":"Atomic resolution structural characterization of recognition of histo-blood group antigens by Norwalk virus","volume":"105","author":"Choi","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2015.12.068_bib0075","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.tim.2005.04.004","article-title":"Norovirus and its histo-blood group antigen receptors: an answer to a historical puzzle","volume":"13","author":"Tan","year":"2005","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.vaccine.2015.12.068_bib0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399407000348","article-title":"Norovirus\u2013host interaction: implications for disease control and prevention","volume":"9","author":"Tan","year":"2007","journal-title":"Expert Rev Mol Med"},{"key":"10.1016\/j.vaccine.2015.12.068_bib0085","doi-asserted-by":"crossref","first-page":"e1000983","DOI":"10.1371\/journal.ppat.1000983","article-title":"Norovirus gastroenteritis, carbohydrate receptors, and animal models","volume":"6","author":"Tan","year":"2010","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2015.12.068_bib0090","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.tim.2011.05.007","article-title":"Norovirus\u2013host interaction: multi-selections by human histo-blood group antigens","volume":"19","author":"Tan","year":"2011","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.vaccine.2015.12.068_bib0095","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1099\/vir.0.83308-0","article-title":"Putative receptor-binding sites of hepatitis E virus","volume":"89","author":"He","year":"2008","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2015.12.068_bib0100","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1016\/j.vaccine.2004.11.064","article-title":"A bacterially expressed particulate hepatitis E vaccine: antigenicity, immunogenicity and protectivity on primates","volume":"23","author":"Li","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.12.068_bib0105","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1016\/j.vaccine.2004.11.065","article-title":"Analysis of hepatitis E virus neutralization sites using monoclonal antibodies directed against a virus capsid protein","volume":"23","author":"Zhang","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.12.068_bib0110","doi-asserted-by":"crossref","first-page":"e63269","DOI":"10.1371\/journal.pone.0063269","article-title":"Norovirus P particle efficiently elicits innate, humoral and cellular immunity","volume":"8","author":"Fang","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2015.12.068_bib0115","doi-asserted-by":"crossref","first-page":"889","DOI":"10.2217\/nnm.12.62","article-title":"Norovirus P particle: a subviral nanoparticle for vaccine development against norovirus, rotavirus and influenza virus","volume":"7","author":"Tan","year":"2012","journal-title":"Nanomedicine (Lond)"},{"key":"10.1016\/j.vaccine.2015.12.068_bib0120","doi-asserted-by":"crossref","first-page":"6233","DOI":"10.1128\/JVI.78.12.6233-6242.2004","article-title":"The P domain of norovirus capsid protein forms dimer and binds to histo-blood group antigen receptors","volume":"78","author":"Tan","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.12.068_bib0125","doi-asserted-by":"crossref","first-page":"12681","DOI":"10.1073\/pnas.1104834108","article-title":"Crystal structure of the human astrovirus capsid spike","volume":"108","author":"Dong","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2015.12.068_bib0130","doi-asserted-by":"crossref","first-page":"7853","DOI":"10.1128\/JVI.03139-12","article-title":"Crystal structure of the avian astrovirus capsid spike","volume":"87","author":"DuBois","year":"2013","journal-title":"J Virol"},{"issue":"6","key":"10.1016\/j.vaccine.2015.12.068_bib0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4161\/hv.28626","article-title":"Vaccine against norovirus","volume":"10","author":"Tan","year":"2014","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.vaccine.2015.12.068_bib0140","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1056\/NEJMoa1101245","article-title":"Norovirus vaccine against experimental human Norwalk virus illness","volume":"365","author":"Atmar","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2015.12.068_bib0145","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1128\/CVI.00196-15","article-title":"Serological correlates of protection against a GII.4 norovirus","volume":"22","author":"Atmar","year":"2015","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2015.12.068_bib0150","doi-asserted-by":"crossref","first-page":"4480","DOI":"10.1016\/j.biomaterials.2013.02.041","article-title":"Polyvalent complexes for vaccine development","volume":"34","author":"Wang","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.vaccine.2015.12.068_bib0155","doi-asserted-by":"crossref","first-page":"8427","DOI":"10.1016\/j.biomaterials.2014.06.021","article-title":"Branched-linear and agglomerate protein polymers as vaccine platforms","volume":"35","author":"Wang","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.vaccine.2015.12.068_bib0160","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.vaccine.2013.11.064","article-title":"A dual vaccine candidate against norovirus and hepatitis E virus","volume":"32","author":"Wang","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.12.068_bib0165","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.virusres.2011.03.015","article-title":"Structure of hepatitis E viral particle","volume":"161","author":"Mori","year":"2011","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2015.12.068_bib0170","doi-asserted-by":"crossref","unstructured":"Ahmad I, Holla RP, Jameel S. Molecular virology of hepatitis E virus. Virus Res;161:47\u201358.","DOI":"10.1016\/j.virusres.2011.02.011"},{"key":"10.1016\/j.vaccine.2015.12.068_bib0175","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1128\/JVI.01835-10","article-title":"Norovirus P particle, a novel platform for vaccine development and antibody production","volume":"85","author":"Tan","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.12.068_bib0180","doi-asserted-by":"crossref","first-page":"14017","DOI":"10.1128\/JVI.79.22.14017-14030.2005","article-title":"The p domain of norovirus capsid protein forms a subviral particle that binds to histo-blood group antigen receptors","volume":"79","author":"Tan","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.12.068_bib0185","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.virol.2010.11.017","article-title":"Terminal modifications of norovirus P domain resulted in a new type of subviral particles, the small P particles","volume":"410","author":"Tan","year":"2011","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2015.12.068_bib0190","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1086\/375742","article-title":"Noroviruses bind to human ABO, lewis, and secretor histo-blood group antigens: identification of 4 distinct strain-specific patterns","volume":"188","author":"Huang","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2015.12.068_bib0195","doi-asserted-by":"crossref","first-page":"6714","DOI":"10.1128\/JVI.79.11.6714-6722.2005","article-title":"Norovirus and histo-blood group antigens: demonstration of a wide spectrum of strain specificities and classification of two major binding groups among multiple binding patterns","volume":"79","author":"Huang","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.12.068_bib0200","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/tbed.12001","article-title":"Serological evidence for a hepatitis E virus-related agent in goats in the United States","volume":"60","author":"Sanford","year":"2013","journal-title":"Transboundary Emerg Dis"},{"key":"10.1016\/j.vaccine.2015.12.068_bib0205","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1099\/vir.0.81545-0","article-title":"Putative neutralization epitopes and broad cross-genotype neutralization of Hepatitis E virus confirmed by a quantitative cell-culture assay","volume":"87","author":"Emerson","year":"2006","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2015.12.068_bib0210","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1099\/vir.0.19478-0","article-title":"Laboratory efforts to cultivate noroviruses","volume":"85","author":"Duizer","year":"2004","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2015.12.068_bib0215","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1086\/656364","article-title":"Serological correlate of protection against norovirus-induced gastroenteritis","volume":"202","author":"Reeck","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2015.12.068_bib0220","doi-asserted-by":"crossref","first-page":"e1005025","DOI":"10.1371\/journal.ppat.1005025","article-title":"A unique human norovirus lineage with a distinct HBGA binding interface","volume":"11","author":"Liu","year":"2015","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2015.12.068_bib0225","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1007\/s00018-008-8228-6","article-title":"Putting endotoxin to work for us: monophosphoryl lipid A as a safe and effective vaccine adjuvant","volume":"65","author":"Casella","year":"2008","journal-title":"Cell Mol Life Sci: CMLS"},{"key":"10.1016\/j.vaccine.2015.12.068_bib0230","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.virol.2008.08.047","article-title":"Noroviral P particle: structure, function and applications in virus\u2013host interaction","volume":"382","author":"Tan","year":"2008","journal-title":"Virology"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16000177?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16000177?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,16]],"date-time":"2018-09-16T04:23:52Z","timestamp":1537071832000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16000177"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":46,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S0264410X16000177"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.12.068","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A trivalent vaccine candidate against hepatitis E virus, norovirus, and astrovirus","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.12.068","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}